SK Biopharmaceuticals Co., Ltd.
KRX:326030.KS
110300 (KRW) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 136,601.569 | 133,995.444 | 113,974.705 | 126,755.848 | 90,338.271 | 77,013.078 | 60,784.359 | 62,767.04 | 88,834.338 | 53,432.883 | 41,144.859 | 230,735.785 | 23,950.608 | 23,969.367 | 139,988.77 | 16,082.776 | 3,923.048 | 2,065.418 | 3,927.784 | 199.074 | 81.659 | 6,508.23 | 117,063.454 |
| Cost of Revenue
| 16,532.398 | 8,745.036 | 15,139.653 | 17,299.301 | 6,795.711 | 9,373.868 | 3,938.222 | 10,563.329 | 13,238.554 | 7,954.924 | 6,011.327 | 16,185.548 | 2,219.705 | 2,084.461 | 1,846.279 | 430.582 | 331.732 | 810.193 | 401.503 | 441.197 | 0 | 73 | 0 |
| Gross Profit
| 120,069.171 | 125,250.408 | 98,835.052 | 109,456.547 | 83,542.56 | 67,639.21 | 56,846.137 | 52,203.712 | 75,595.784 | 45,477.96 | 35,133.531 | 214,550.236 | 21,730.902 | 21,884.905 | 138,142.491 | 15,652.194 | 3,591.316 | 1,255.225 | 3,526.281 | -242.123 | 81.659 | 6,435.23 | 117,063.454 |
| Gross Profit Ratio
| 0.879 | 0.935 | 0.867 | 0.864 | 0.925 | 0.878 | 0.935 | 0.832 | 0.851 | 0.851 | 0.854 | 0.93 | 0.907 | 0.913 | 0.987 | 0.973 | 0.915 | 0.608 | 0.898 | -1.216 | 1 | 0.989 | 1 |
| Reseach & Development Expenses
| 0 | 43,553.521 | 35,674.564 | 38,631.8 | 38,765.362 | 31,473.938 | 28,258.036 | 34,722.942 | 31,044.252 | 31,694.765 | 25,354.784 | 28,128.9 | 29,578.468 | 30,810.348 | 26,008.619 | 31,183.295 | 28,882.865 | 21,056.261 | 27,318.964 | 78,500.912 | 27,680.199 | 35,118.663 | 34,912.988 |
| General & Administrative Expenses
| 100,725.247 | 99,204.851 | 91,733.259 | 16,605.845 | 94,254.61 | 86,575.266 | 11,949.767 | 17,862.679 | 17,169.29 | 16,017.697 | 11,385.758 | 16,150.14 | 12,233.914 | 12,355.193 | 9,222.412 | 12,992.577 | 12,028.608 | 12,381.806 | 16,298.606 | -1,557.377 | 1,944.974 | 6,714.091 | 1,959.314 |
| Selling & Marketing Expenses
| 0 | -47,882.555 | -40,524.93 | 8,796.308 | 9,165.194 | 10,793.803 | 11,386.567 | 18,410.329 | 10,538.599 | 10,097.001 | 10,840.158 | 14,220.577 | 8,090.166 | 11,167.394 | 6,361.465 | 7,265.265 | 6,340.872 | 5,497.229 | 6,257.468 | 74.853 | 252.163 | 108.146 | 53.573 |
| SG&A
| 100,725.247 | 51,322.296 | 51,208.329 | 55,064.924 | 94,254.61 | 86,575.266 | 23,336.334 | 36,273.008 | 27,707.889 | 26,114.698 | 22,225.916 | 30,370.717 | 20,324.08 | 23,522.587 | 15,583.877 | 20,257.842 | 18,369.48 | 17,879.035 | 22,556.074 | -1,482.524 | 2,197.137 | 6,822.237 | 2,012.887 |
| Other Expenses
| 0 | 30,428.464 | -1,697.343 | -977.665 | -188,509.22 | -173,150.533 | 27,908.015 | 25,828.421 | 26,091.076 | 27,740.552 | 24,690.712 | -4.085 | -13.538 | -473.556 | -3.264 | -14.95 | -495.401 | 0.015 | 2.162 | 61.657 | 185.806 | 47.927 | 77.74 |
| Operating Expenses
| 100,725.247 | 96,052.243 | 88,580.236 | 94,674.389 | -94,254.61 | -86,575.267 | 79,502.385 | 96,824.371 | 84,843.217 | 85,550.015 | 72,271.412 | 80,504.618 | 71,668.737 | 86,966.251 | 62,210.729 | 69,161.732 | 66,627.036 | 59,091.234 | 68,643.838 | 65,782.589 | 50,574.196 | 44,843.654 | 41,396.517 |
| Operating Income
| 19,343.924 | 26,045.557 | 10,254.815 | 14,782.158 | -10,712.05 | -18,936.057 | 2,722.814 | -44,620.659 | -9,247.433 | -40,072.055 | -37,137.881 | 134,045.618 | -49,937.834 | -65,081.345 | 75,931.762 | -53,509.538 | -63,035.72 | -57,836.009 | -65,117.557 | -66,024.711 | -50,492.538 | -38,408.424 | 75,666.937 |
| Operating Income Ratio
| 0.142 | 0.194 | 0.09 | 0.117 | -0.119 | -0.246 | 0.045 | -0.711 | -0.104 | -0.75 | -0.903 | 0.581 | -2.085 | -2.715 | 0.542 | -3.327 | -16.068 | -28.002 | -16.579 | -331.66 | -618.332 | -5.902 | 0.646 |
| Total Other Income Expenses Net
| -9,843.4 | -2,250.031 | -2,537.497 | -11,268.545 | -9,112.833 | -6,116.388 | 20,162.199 | -1,928.497 | -7,372.256 | -4,218.151 | 2,128.067 | -81,364.597 | 2,035.751 | -1,181.327 | 53,430.064 | 2,164.98 | -9.644 | -1,594.618 | -921.224 | -75.862 | -694.893 | -3,753.854 | -3,566.826 |
| Income Before Tax
| 9,500.524 | 23,795.526 | 13,223.006 | 13,551.36 | -19,824.882 | -25,052.445 | -2,494.049 | -46,549.153 | -16,619.692 | -44,290.208 | -35,009.811 | 52,681.02 | -44,503.623 | -66,262.672 | 129,361.823 | -51,344.558 | -63,045.365 | -59,430.627 | -66,088.78 | -66,100.574 | -50,236.863 | -42,162.279 | 72,100.11 |
| Income Before Tax Ratio
| 0.07 | 0.178 | 0.116 | 0.107 | -0.219 | -0.325 | -0.041 | -0.742 | -0.187 | -0.829 | -0.851 | 0.228 | -1.858 | -2.764 | 0.924 | -3.193 | -16.071 | -28.774 | -16.826 | -332.041 | -615.201 | -6.478 | 0.616 |
| Income Tax Expense
| 3,192.029 | -762.535 | -1,939.557 | -5,232.056 | -1,410.797 | -1,710.098 | -125.323 | -2,689.737 | -1,657.177 | 1,113.174 | 195.754 | 5,554.122 | -229.451 | 735.057 | 371.179 | 6,770.016 | 28.736 | 199.131 | 506.401 | -13,032.619 | 6.792 | 474.501 | -1,194.29 |
| Net Income
| 9,654.749 | 28,135.894 | 12,832.074 | 6,759.789 | -13,931.565 | -23,342.347 | -2,368.726 | -43,859.416 | -14,962.515 | -45,403.382 | -35,205.565 | 47,126.898 | -44,274.172 | -66,997.729 | 128,990.644 | -58,114.574 | -63,074.101 | -59,629.757 | -66,595.182 | -53,067.955 | -50,243.655 | -42,636.78 | 72,100.11 |
| Net Income Ratio
| 0.071 | 0.21 | 0.113 | 0.053 | -0.154 | -0.303 | -0.039 | -0.699 | -0.168 | -0.85 | -0.856 | 0.204 | -1.849 | -2.795 | 0.921 | -3.613 | -16.078 | -28.871 | -16.955 | -266.575 | -615.285 | -6.551 | 0.616 |
| EPS
| 123.28 | 359 | 163.86 | 86.32 | -177.9 | -298.06 | -30.25 | -560.05 | -191.06 | -580 | -450 | 601.4 | -565.35 | -855.51 | 1,647 | -742.08 | -850 | -913 | -1,025 | -816.45 | -773 | -656 | 1,109 |
| EPS Diluted
| 123.28 | 359.27 | 163.86 | 86.32 | -177.9 | -298.06 | -30.25 | -560.05 | -191.06 | -579.77 | -449.55 | 601.4 | -565 | -855 | 1,647 | -742.08 | -850 | -913 | -1,025 | -816.45 | -773 | -656 | 1,109 |
| EBITDA
| 120,069.171 | 30,370.856 | 14,662.808 | 19,274.002 | -8,535.236 | -17,196.777 | -3,432.135 | -41,224.755 | -6,832.675 | -38,291.737 | -34,057.053 | 139,695.438 | -41,347.258 | -63,110.571 | 78,762.418 | -47,583.561 | -58,980.485 | -55,038.193 | -62,986.445 | -63,324.246 | -48,199.248 | -37,940.453 | 77,071.09 |
| EBITDA Ratio
| 0.879 | 0.227 | 0.128 | 0.152 | 0.925 | 0.878 | 0.1 | -0.715 | -0.077 | -0.631 | -0.672 | 0.232 | -1.557 | -2.621 | 0.946 | -3.086 | -15.012 | -26.642 | -16.036 | -317.709 | -589.907 | -5.83 | 0.648 |